Local Reaction to Hyaluronidase: Swelling, Itching, Management

Hyaluronidase is the reversal tool for hyaluronic acid and, for exactly that reason, must be available whenever filler is used. What is talked about less is what happens to the skin after it is injected. Most of the time, nothing more than mild swelling. In some patients, though, itching, redness, warmth, and swelling appear and worry the patient and, sometimes, the professional.

This page deals with the local reaction to the enzyme: how to recognize it, how to separate it from what is expected and from a true allergy, what to advise, and when to recheck. It is a clinical-level review, with no dosing regimen. Volumes and protocols of use follow the product label and the judgment of the qualified professional, according to the rules of their professional council.

Why does the area react after hyaluronidase?

There are at least three overlapping mechanisms, and it is rarely possible to separate them just by looking.

• Injection trauma. The needle or cannula, the volume of fluid, and tissue manipulation already cause swelling and redness, as with any injection.
• Effect of dissolving. By breaking down hyaluronic acid, the enzyme releases fragments and changes water dynamics in the tissue. The area may look more swollen for a few hours before settling.
• Response to the enzyme itself. It is a protein, and the skin can respond with a local reaction or, more rarely, a hypersensitivity reaction.

Since all three coexist, the practical criteria are intensity, pattern, and speed. Small swelling confined to the site that improves within a few days is the expected picture. Intense itching, plaques, and redness that advance beyond the area are signs of a reaction.

What is the difference between a local reaction and a systemic allergy?

The table organizes what usually separates the two pictures. The boundary between them is not sharp, and clinical judgment in the moment is worth more than any list.

If signs from the right-hand column appear, stop the procedure and follow the protocol described in anaphylaxis in the HOF clinic. To tell it apart from a simple faint, see vasovagal syncope in the clinic.

How do you investigate allergy before using it?

Hyaluronidase is often used in an emergency, and in that situation the benefit outweighs the theoretical risk. When use is elective, however, there is time to talk. The medical history can include:

• History of allergy to medications, insect stings, and other products.
• Previous reactions to hyaluronidase, including in past dissolutions, and how they went.
• Active allergic diseases, such as asthma and severe dermatitis.
• Ongoing medications, to be assessed by the professional.

There is discussion in the literature about prior skin testing, with different opinions on when it makes sense. The page hyaluronidase allergy and testing details the debate. Routine use and clinic organization are in hyaluronidase in the clinic.

What should you expect in the first few days?

The most frequent course is swelling that peaks in the first hours, may be bigger the next morning, and then recedes. In the periorbital area and the lips, where the tissue is loose and richly vascularized, swelling tends to be more evident and lasts a little longer. There may be tenderness to touch and mild itching.

This timeline is a reference map, not a promise. Each patient reacts differently, and in-person assessment always prevails.

What should you tell the patient?

Simple instructions reduce anxiety and late-night calls. In general, it is worth explaining that some swelling is expected, that redness fades within days, and that assessing the result of the dissolution only makes sense after the swelling goes down. Measures such as a cold compress follow the professional's recommendation.

Also make clear that the final assessment of volume only counts after the swelling period. Judging the result on the day of injection leads to unnecessary repeat doses. The page on when to dissolve a filler discusses the decision to dissolve and when to reassess.

When should you reassess urgently?

Some situations call for a quick return or referral, even if they started as "just swelling":

• Disproportionate pain, pallor, or a purplish look to the skin, which may resemble a vascular complication. See vascular danger zones of the face.
• Vision changes in someone treated in the periorbital, nasal, or glabellar area: this is an ophthalmologic emergency.
• Fever, intense warmth, and an area that hardens or becomes fluctuant, suggesting infection. See abscess after filler.
• A local reaction that spreads or persists for more than a few days.

If hyaluronidase was used precisely to treat suspected occlusion, the reasoning changes: swelling is monitored together with skin perfusion, and follow-up is closer. These scenarios have their own pages, such as glabellar vascular occlusion and visual complication after filler.

What should you document?

In the patient record, note the reason the enzyme was injected, the areas, the product and lot of hyaluronidase (traceability), the findings before and after, the instructions given, and the reaction observed, with the time. If there was a relevant local reaction, record standardized photos and the course at each visit. Relevant adverse events can be reported; the path is in adverse event reporting in Notivisa.

The dissolution-specific informed consent should mention swelling, local reaction, the possibility of incomplete dissolution, and the rare chance of allergy. Without it, the patient tends to interpret any swelling as a mistake.

What if the patient has had a reaction before?

Someone who has already had a significant reaction to the enzyme needs a conversation of their own. Depending on the type of reaction, the professional may decide on alternatives, referral to an allergist, or use in a setting with more infrastructure. The decision is individual and should be documented, with the explanation given to the patient. In a vascular emergency, the risk-benefit calculation is different, and that assessment belongs to whoever is with the patient.

Where Harmy helps

Harmy does not treat any reaction, but it can help in the conversation before dissolving. When the patient arrives dissatisfied with the volume of an area, the projection from a new front-facing photo shows how the face might look with less volume there, and that helps decide whether dissolving is really what they want.

Summary for practice

Local reaction to hyaluronidase is usually mild and self-limiting, but correct management starts with recognizing what is not local. Ask about allergies, have the emergency plan ready, explain the warning signs, photograph, document, and assess the result only after the swelling period. When in any doubt about the picture, examine the patient again.